Cookies

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this repository, you give consent for essential cookies to be used. You can read more about our Privacy and Cookie Policy.


Durham Research Online
You are in:

The histamine H4 receptor is a potent inhibitor of adhesion-dependent degranulation in human neutrophils.

Dib, K. and Perecko, T. and Jenei, V. and McFarlane, C. and Comer, C. and Brown, V. and Katebe, M. and Scheithauer, T. and Thurmond, R.L. and Chazot, P.L. and Ennis, M. (2014) 'The histamine H4 receptor is a potent inhibitor of adhesion-dependent degranulation in human neutrophils.', Journal of leukocyte biology., 96 (3). pp. 411-419.

Abstract

The histamine H4 receptor regulates the inflammatory response. However, it is not known whether this receptor has a functional role in human neutrophils. We found that fMLP (1 μM), but not histamine (0.1–1 μM), induced Mac-1-dependent adhesion, polarization, and degranulation (release of lactoferrin). A pretreatment of neutrophils with histamine (0.001–1 μM) or JNJ 28610244 (0.1–10 μM), a specific H4 receptor agonist, led to inhibition of degranulation. Total inhibition of degranulation was obtained with 0.1 μM histamine and 10 μM JNJ 28610244. Furthermore, such inhibition by histamine of degranulation was reversed by JNJ 7777120 and JNJ 28307474, two selective H4 receptor antagonists. However, neither histamine nor the H4 receptor agonist JNJ 28610244 prevented fMLP-induced, Mac-1-dependent adhesion, indicating that the H4 receptor may block signals emanating from Mac-1-controlling degranulation. Likewise, engagement of the H4 receptor by the selective agonist JNJ 28610244 blocked Mac-1-dependent activation of p38 MAPK, the kinase that controls neutrophil degranulation. We also show expression of the H4 receptor at the mRNA level in ultrapure human neutrophils and myeloid leukemia PLB-985 cells. We concluded that engagement of this receptor by selective H4 receptor agonists may represent a good, therapeutic approach to accelerate resolution of inflammation.

Item Type:Article
Full text:Publisher-imposed embargo
(AM) Accepted Manuscript
File format - PDF (Copyright agreement prohibits open access to the full-text)
(489Kb)
Status:Peer-reviewed
Publisher Web site:https://doi.org/10.1189/jlb.2AB0813-432RR
Date accepted:11 April 2014
Date deposited:29 April 2016
Date of first online publication:September 2014
Date first made open access:No date available

Save or Share this output

Export:
Export
Look up in GoogleScholar